コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ermediates to transform them ultimately into isoquinoline.
2 solution-phase Pomeranz-Fritsch synthesis of isoquinoline.
3 ine formation and reduction of the resulting isoquinoline.
4 -substituted derivatives of 1H-pyrrolo[3,2-c]isoquinoline.
5 s including indole, thiophene, pyridine, and isoquinoline.
6 rrolo[3,2-c][1,2,4]triazolo[5,1-a] or [3,4-a]isoquinolines.
7 aroyl-substituted imidazo-/benzimidazo-fused isoquinolines.
8 tandem synthesis of indolo and pyrrolo[2,1-a]isoquinolines.
9 nd ultimately to imidazo[4,5-c]pyridines and isoquinolines.
10 hyl-2, 1-ethanediyl)]-bis(5-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione] dimethanesulfonate) is a nov
13 the headpiece of the 4-(phenylaminomethylene)isoquinoline-1,3(2H,4H)-dione, a basic amine substituent
14 ethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3- diones with substituents at the 4, 8,
16 )-dione and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-dione derivatives reported here
20 w 2-[2'-(dimethylamino)ethyl]-3H-dibenz[de,h]isoquinoline-1,3-diones with substituents at the 6- and
23 ,2,3,5,6alpha,10beta-hexahydropyrrol o[2,1-a]isoquinoline ((11)C-McN 5652) was the first PET radiotra
24 thesis of diversely substituted indolo[2,1-a]isoquinolines 11a-r, pyrrolo[2,1-a]isoquinolines 12a-d,
25 dro-6-[4-(methylthio)phenyl]pyrrolo-[2,1-a]- isoquinoline ([11C]McN 5652) is the first PET radioligan
26 olo[2,1-a]isoquinolines 11a-r, pyrrolo[2,1-a]isoquinolines 12a-d, and indolo-, pyrrolo[2,1-f][1,6]nap
27 d by benzo[a]quinolizine 8 and pyrrolo[2,1-a]isoquinoline 13, with an interest in stereochemistry and
29 (methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydroxybut-1-yl)
30 irect synthesis of bisindolo-, pyrrolo[2,1-a]isoquinolines 15a-g, a regioisomer of the bisindolo[1,2-
31 m pyrolysis (FVP) of 1-(5-(13)C-5-tetrazolyl)isoquinoline 18 generates 1-((13)C-diazomethyl)isoquinol
32 oxy-2,3,4,6,7,11b-hex ahydro-1H-pyrido[2,1-a]isoquinoline ((18)F-AV-266), and (2S,3R,11bR)-9-(3-fluor
33 oquinoline 18 generates 1-((13)C-diazomethyl)isoquinoline 19 and 1-isoquinolyl-((13)C-carbene) 22, wh
34 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affec
35 cyclic 1,2,3,5,10,10a-hexahydroimidazo[1,5-b]isoquinolines 1a-c and 2,3,10,10a-tetrahydroimidazo[1,5-
37 the complex of hCA II with 4-(3,4-dihydro-1H-isoquinoline-2-carbonyl)benzenesulfonamide (3) (PDB code
38 les (5, 7, 10, 13), 5,6-dihydroindolo[2, 1-a]isoquinolines (20, 21), and 6,7-dihydro-5H-benzo[c]azepi
39 (methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (21) and cis-6-allyl-5,6,12,13-tetrahydro-2
41 (methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (22), both of which displayed submicromolar
42 yl)-5,6-dihydro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2, 3-dimethoxy-8,9-(methyl
44 d compounds 25 and 26, the 5,6-dihydrobenz[f]isoquinoline 28, and the benzofuro[3,2-c]pyridine 30.
45 simple straightforward syntheses of triazolo isoquinolines (3) and isochromenes (7) from 2-alkynylben
49 henyl)methyl-1,2,3,4,4a,5,6,7,8,8a-decahydro isoquinoline-3-carboxylic acid), which antagonizes kaina
52 oped for the synthesis of hexahydro-1H-spiro[isoquinoline-4,4'-pyran] derivatives through the condens
54 ey intermediates in the synthesis are benz[g]isoquinoline-5,10-diones which are substituted at positi
55 l)thieno[2',3':5,6]pyrido[3,4-g]thieno[3,2-c]isoquinoline-5,11(4H, 10H)-dione) (PNTPD); poly(5-(4,10-
56 thieno[2',3':5',6']pyrido[3,4-g]thieno[3,2-c]isoquinoline-5,11(4H,10H)-dione and fluorenedicyclopenta
57 d 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36) (3) is among the fe
58 fore, NBS furnished direct conversion to the isoquinoline-5,8-dione; alternatively, N-haloimides of c
59 lyzed synthesis of oxazine/benzoxazine-fused isoquinolines 5a-q and naphthyridines 6a-v by the reacti
60 3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propyla mino}-propane bis(trifluoroaceta
61 9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-bindi
67 lecule pharmaceutical, a naturally occurring isoquinoline alkaloid, and endogenous compounds includin
70 hrome P450 genes (CYP28) from two species of isoquinoline alkaloid-resistant Drosophila and the cosmo
72 ipecac alkaloids, a series of monoterpenoid-isoquinoline alkaloids such as emetine and cephaeline, w
73 he asymmetric synthesis of chiral nonracemic isoquinoline alkaloids, a family of natural products sho
74 aromatic substitution reactions to make the isoquinoline allows direct access to analogues possessin
76 sentatives of 7H-imidazo[2,1-a]pyrrolo[3,2-c]isoquinoline and 1H-imidazo[2,1-a]pyrrolo[3,4-c]isoquino
79 hod affords unprecedented fluorinated benz[f]isoquinoline and octahydroisoquinoline products in high
83 plex I inhibitors, including rotenone, MPP+, isoquinoline and tetrahydroisoquinoline, induce apoptosi
84 enantioselective synthesis of pyrrolo[2,1-a]isoquinolines and an attempted synthesis of the alkaloid
92 substituted pyridines, thiazoles, quinoline, isoquinolines, and pyrazine (1-9 and 28) has been studie
93 es, deazapurines, benzimidazole, quinolines, isoquinolines, and pyridines were efficiently deuterated
98 rolo[3,2-c][1,2,4]triazolo[5,1-a] and [3,4-a]isoquinolines, as well two more new heterocyclic systems
102 including the beta-carboline harmine and the isoquinoline berberine, that ameliorated certain aspects
103 ave investigated the gas-phase production of isoquinoline by performing collisional activation on ben
106 -chlorophenyl]-N-methyl-N-[1-methylpropyl]-3-isoquinoline carboxamide)--a positron-emitting ligand th
108 2-chlorphenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carboxamide (PK11195) is a ligand specific
109 identified 1-(2-chlorophenylmethylpropyl)-3-isoquinoline-carboxamide (PK11195), a typical peripheral
110 c acid-6'-carboxylic acid, L = 4-picoline or isoquinoline) catalysts proceed through a single-site wa
113 gy provides a simple and convenient route to isoquinolines containing an aryl, alkyl, or vinylic grou
115 developed in our laboratories to build a key isoquinoline-containing intermediate comprising the enti
116 oduction of substituents at the C1 carbon of isoquinoline core along with syntheses applying various
117 ing of the nitrogen-containing ring B of the isoquinoline core by the formation of bonds between C1-N
119 nes to a series of potent and CHK1-selective isoquinolines demonstrates how fragment-growing and scaf
120 aporphine cores through reactions between an isoquinoline derivative and silylaryl triflates promoted
121 To investigate the effectiveness of a novel isoquinoline derivative, EDL-155, in killing retinoblast
122 hat high quantum yields of the quinoline and isoquinoline derivatives are a result of the relative re
124 ization gave general access to pyrrolo[2,1-a]isoquinoline derivatives under very mild conditions.
125 sine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives was investigated by examining t
126 C(4) of the 2-azabuta-1,3-dienes, providing isoquinoline derivatives, can occur at elevated temperat
133 nervous system regeneration to show that the isoquinoline drug praziquantel (PZQ) acts as a small mol
134 tic method to prepare partially hydrogenated isoquinolines efficiently from silver-mediated [3,3]-sig
135 a binding motif led to the identification of isoquinoline ethyl urea 13 as a promising starting point
136 2,2'-bipyridine-6,6'-dicarboxylate; isoq is isoquinoline) exists as the open-arm chelate, [Ru(II)(CO
137 (sp(2))-H functionalization of pyridines and isoquinolines for the synthesis of imidazo[1,2-a]pyridin
138 e triflate and a boronate ester, followed by isoquinoline formation and reduction of the resulting is
139 monium acetate, and a variety of substituted isoquinolines, furopyridines, and thienopyridines is pre
140 potency, they were ranked in the order of 5-isoquinoline > 8-quinoline = 8-quinazoline > 8-isoquinol
141 oquinoline > 8-quinoline = 8-quinazoline > 8-isoquinoline > or = cinnoline approximately phthalazine
142 ncluding N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H-89), adenosine 3'-5'cyclic monophosphoth
143 nhibitor N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89) or the p38 mitogen-activated protein
145 ocked by N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89)] and extracellular signal-regulated k
148 quinoline and 1H-imidazo[2,1-a]pyrrolo[3,4-c]isoquinoline heterocyclic skeletons, which were further
149 ctive synthesis of the hexahydroimidazo[1,5b]isoquinoline (HHII) scaffold as a surrogate for the ster
150 imethoxy-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline hydrochloride (14) is a strong topoisomeras
151 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride (19a), which proved to be a v
152 roxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline hydrochloride 6 and the resolution of its e
153 dimethoxy-(m ethylenedioxy)-11H-indeno[1,2-c]isoquinoline hydrochloride), the cytotoxicity of bisinde
155 rolo[3,4-c][1,2,4]triazolo[5,1-a] and [3,4-a]isoquinolines, in good yields without triazole ring clea
156 fluorenones and fluorenones containing fused isoquinoline, indole, pyrrole, thiophene, benzothiophene
158 gression of a potent and selective series of isoquinoline inhibitors of IkappaB kinase-beta (IKK-beta
159 itivity to the rat P2X7R; this suggests that isoquinolines interact with residues in the amino-termin
160 isomeric pyrrolo[3,2-c][1,2,4]triazolo[3,4-a]isoquinolines involves, besides the triazole ring openin
161 e a novel "one-pot" process to assemble aryl(isoquinoline)iodonium salts in 40-94 % yields from mesoi
164 -2,3,3a,4,5,6,9b-hexahydro-1H-pyrrolo-[3,2h]-isoquinoline) is a conformationally restricted analog of
165 effect was inhibited by oxidized ATP and the isoquinoline KN-62, two known P2X7 receptor antagonists.
166 m, cyclization of each olefin afforded fused isoquinoline lactams as single diastereomers epimeric at
167 -TsOH, cyclization occurred to produce fused isoquinoline lactams by a mechanism that involves an ini
169 nd involving the ring nitrogen-2 atom of the isoquinoline must be preserved, but that the ring can fl
175 onverted into aminoallenylidene isochromans, isoquinolines, or tetrahydronaphtalenes with silver(I) s
176 however, a new, readily available bidentate isoquinoline-oxazoline ligand furnishes excellent ee's a
178 e, tetrahydroisoquinoline, 5,6-dihydrobenz[f]isoquinoline, pyrindine, and pyridine heterocycles have
181 successfully used for this reaction, such as isoquinolines, quinoline, phenanthridine, quinazoline, p
182 g between electron-deficient N-heterocycles (isoquinoline, quinolines, and quinoxalines) and methylbe
183 are novel but poorly characterized cytotoxic isoquinoline quinones and iminoquinones identified in ex
184 hy l-5,6,7,8-tetrahydro-[1,3]-di-oxolo[4,5-g]isoquinoline (Red-Br-nos), exerts a novel autophagic res
186 lacement of the nucleophilic co-catalyst for isoquinoline resulted in a divergent reaction pathway an
187 reparation of a wide range of (18) F-labeled isoquinolines resulting in up to 92 % radiochemical conv
188 e-activity relationship between the nitrated isoquinoline ring and a methylenedioxy-substituted inden
190 bromo, nitro, acetyl, and aminomethyl on the isoquinoline ring resulted in a significant loss of acti
191 ubsite of the inhibitor which identified the isoquinoline ring system as a key template for improving
192 A methoxy moiety at the C6 position of this isoquinoline ring system proved to be optimal with respe
193 ses pointed to a proton at position-9 of the isoquinoline ring that can be modified without compromis
194 austive series was prepared using a nitrated isoquinoline ring that has been previously demonstrated
200 Moreover, it was possible to synthesize the isoquinoline salts from readily available starting mater
203 g H89 (N-[2-(p-bromo-cinnamylamino)-ethyl]-5-isoquinoline-sulfon-amide 2HCl) and Ht31, disruptors of
204 d H89 (N-[2-(p-bromo-cinnamylamino)-ethyl]-5-isoquinoline-sulfon-amide 2HCl), as well as by the AKAP
206 n signals was inferred from experiments with isoquinoline sulfonamide protein kinase inhibitors.
207 G (PKG) inhibitor N-[2-(methylamino)ethy]-5-isoquinoline-sulfonamide (H8) blocks NECA, hydroxylamine
208 fully blocked by N-[2-(methylamino)ethyl]-5'-isoquinoline-sulfonamide and 2-[1-(3-dimethylaminopropyl
209 Rhodobacter sphaeroides (10 microg/ml); the isoquinoline-sulfonamide H-8 (10 and 100 microM), which
210 n kinase, N-[2(p-bromocinnamylamino)ethyl]-5-isoquinoline-sulfonamide hydrochloride (H-89) and myrist
214 ,5,12,12a alpha-octahydroquinolino-[2,3,3-g]-isoquinoline; TAN67) were coadministered in GH(3)MORDOR
217 se complexes reacted with 2,2'-bipyridine or isoquinoline, they facilitated the alkyl migration of th
219 n of the trans diastereomers to indeno[1,2-c]isoquinolines using selenoxide elimination and Friedel-C
223 Imidazo[1,2-a]pyrazine and imidazo[2,1-a]isoquinoline were also obtained in good yields under sim
226 es a valuable new route to 3,4-disubstituted isoquinolines with aryl, allylic, benzylic, 1-alkynyl, a
227 cts can be readily converted to indeno[1,2-c]isoquinolines with thionyl chloride, the trans products
228 zo[1,2-a]pyridines and 2-phenylimidazo[2,1-a]isoquinolines with vinyl azides under mild aerobic condi
229 -methyle nedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline) with both similarities and differences fro
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。